-
1
-
-
64149109548
-
Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia
-
Horst W, Klein MW, Williams D, Werder SF. Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia. Neuropsychiatric Disease and Treatment 2005;1(4):349-55.
-
(2005)
Neuropsychiatric Disease and Treatment
, vol.1
, Issue.4
, pp. 349-355
-
-
Horst, W.1
Klein, M.W.2
Williams, D.3
Werder, S.F.4
-
2
-
-
33751324165
-
A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder
-
Baker A, Richmond R, Haile M, Lewin TJ, Carr VJ, Taylor RL, et al. A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. American Journal of Psychiatry 2006;163:1934-42.
-
(2006)
American Journal of Psychiatry
, vol.163
, pp. 1934-1942
-
-
Baker, A.1
Richmond, R.2
Haile, M.3
Lewin, T.J.4
Carr, V.J.5
Taylor, R.L.6
-
3
-
-
33847762234
-
Characteristics of smokers with a psychotic disorder and implications for smoking interventions
-
Baker A, Richmond R, Haile M, Lewin TJ, Carr VJ, Taylor RL, et al. Characteristics of smokers with a psychotic disorder and implications for smoking interventions. Psychiatry Research 2007;150:141-152.
-
(2007)
Psychiatry Research
, vol.150
, pp. 141-152
-
-
Baker, A.1
Richmond, R.2
Haile, M.3
Lewin, T.J.4
Carr, V.J.5
Taylor, R.L.6
-
4
-
-
77949888097
-
Cigarette smoking and psychosis: naturalistic follow up 4 years after an intervention trial
-
Vol. 44, issue 4:-
-
Baker A, Richmond R, Lewin TJ, Kay-Lambkin F. Cigarette smoking and psychosis: naturalistic follow up 4 years after an intervention trial. Australian and New Zealand Journal of Psychiatry 2010; Vol. 44, issue 4:342-50.
-
(2010)
Australian and New Zealand Journal of Psychiatry
, pp. 342-350
-
-
Baker, A.1
Richmond, R.2
Lewin, T.J.3
Kay-Lambkin, F.4
-
5
-
-
84961915048
-
Intervention for tobacco dependence among people with a psychotic illness: RCT with one year outcome
-
Richmond RL, Baker A, Haile M, Carr V, Lewin T, Wilhelm K, et al. Intervention for tobacco dependence among people with a psychotic illness: RCT with one year outcome. Nicotine & Tobacco Research 2005;7(4):681.
-
(2005)
Nicotine & Tobacco Research
, vol.7
, Issue.4
, pp. 681
-
-
Richmond, R.L.1
Baker, A.2
Haile, M.3
Carr, V.4
Lewin, T.5
Wilhelm, K.6
-
6
-
-
84873283573
-
A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalised schizophrenic patients
-
epub
-
Chen H-K, Lan T-H, Wu B-J. A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalised schizophrenic patients. European Archives of Psychiatry and Clinical Neuroscience 2012;epub:doi: 10.1007/s00406-012-0338-3.
-
(2012)
European Archives of Psychiatry and Clinical Neuroscience
-
-
Chen, H.-K.1
Lan, T.-H.2
Wu, B.-J.3
-
7
-
-
84888132163
-
Increased smoking cessation and reduction: Two years following a smoking cessation trial in patients with schizophrenia
-
New Orleans, Louisiana, USA
-
Evins A, Cather C, Goff DC, Rigotti NA. Increased smoking cessation and reduction: Two years following a smoking cessation trial in patients with schizophrenia. Conference Abstract of Society for Research on Nicotine and Tobacco 9th Annual Meeting: New Orleans, Louisiana, USA. 2003.
-
(2003)
Conference Abstract of Society for Research on Nicotine and Tobacco 9th Annual Meeting
-
-
Evins, A.1
Cather, C.2
Goff, D.C.3
Rigotti, N.A.4
-
8
-
-
0035191220
-
A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia
-
Evins A, Mays VK, Rigotti NA, Tisdale T, Cather C, Goff DC. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine & Tobacco Research 2001;3(4):397-403.
-
(2001)
Nicotine & Tobacco Research
, vol.3
, Issue.4
, pp. 397-403
-
-
Evins, A.1
Mays, V.K.2
Rigotti, N.A.3
Tisdale, T.4
Cather, C.5
Goff, D.C.6
-
9
-
-
2342620106
-
Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction
-
Evins AE, Cather C, Rigotti NA, Freudenreich O, Henderson DC, Olm-Shipman CM, et al. Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction. Journal of Clinical Psychiatry 2004;65(3):307-11.
-
(2004)
Journal of Clinical Psychiatry
, vol.65
, Issue.3
, pp. 307-311
-
-
Evins, A.E.1
Cather, C.2
Rigotti, N.A.3
Freudenreich, O.4
Henderson, D.C.5
Olm-Shipman, C.M.6
-
10
-
-
85036501897
-
Reduction In tobacco use in schizophrenia with bupropion SR and Cognitive Behavioral Therapy
-
Arlington, Virginia, USA
-
Evins AE, Mays VK, Rigotti NA, Tisdale T, Daigle A, Goff DC. Reduction In tobacco use in schizophrenia with bupropion SR and Cognitive Behavioral Therapy. Conference abstract of Society for Research on Nicotine and Tobacco 6th Annual Meeting: Arlington, Virginia, USA. 2000.
-
(2000)
Conference abstract of Society for Research on Nicotine and Tobacco 6th Annual Meeting
-
-
Evins, A.E.1
Mays, V.K.2
Rigotti, N.A.3
Tisdale, T.4
Daigle, A.5
Goff, D.C.6
-
11
-
-
21044453294
-
A double-blind placebo-controlled trial of bupropion Sustained-Release for smoking cessation in schizophrenia
-
Evins A, Cather C, Deckersbach T, Freudenreich O, Culhane MA, Olm-Shipman CM, et al. A double-blind placebo-controlled trial of bupropion Sustained-Release for smoking cessation in schizophrenia. Journal of Clinical Psychopharmacology 2005;25(3):218-25.
-
(2005)
Journal of Clinical Psychopharmacology
, vol.25
, Issue.3
, pp. 218-225
-
-
Evins, A.1
Cather, C.2
Deckersbach, T.3
Freudenreich, O.4
Culhane, M.A.5
Olm-Shipman, C.M.6
-
12
-
-
26644450242
-
Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia
-
Evins A, Deckersbach T, Cather C, Freudenreich O, Culhane MA, Henderson DC, et al. Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. Journal of Clinical Psychiatry 2005;66(9):1184-90.
-
(2005)
Journal of Clinical Psychiatry
, vol.66
, Issue.9
, pp. 1184-1190
-
-
Evins, A.1
Deckersbach, T.2
Cather, C.3
Freudenreich, O.4
Culhane, M.A.5
Henderson, D.C.6
-
13
-
-
77951726850
-
Smoking cessation in schizophrenia: A double blind placebo controlled trial of bupropion SR added to cognitive behavioral therapy
-
Evins AE, Cather C, Culhane M, Freudenreich O, Rigotti NA, Goff DC. Smoking cessation in schizophrenia: A double blind placebo controlled trial of bupropion SR added to cognitive behavioral therapy. Biological Psychiatry 2004;55:226S.
-
(2004)
Biological Psychiatry
, vol.55
, pp. 226S
-
-
Evins, A.E.1
Cather, C.2
Culhane, M.3
Freudenreich, O.4
Rigotti, N.A.5
Goff, D.C.6
-
14
-
-
77951757583
-
A placebo controlled trial of bupropion SR for smoking cessation in schizophrenia (POS3-49)
-
New Orleans, Louisiana, USA
-
Evins AE, Cather C, Goff DC, Olm-Shipman C, Rigotti NA. A placebo controlled trial of bupropion SR for smoking cessation in schizophrenia (POS3-49). Conference abstract of Society for Research on Nicotine and Tobacco 9th Annual Meeting: New Orleans, Louisiana, USA. 2003.
-
(2003)
Conference abstract of Society for Research on Nicotine and Tobacco 9th Annual Meeting
-
-
Evins, A.E.1
Cather, C.2
Goff, D.C.3
Olm-Shipman, C.4
Rigotti, N.A.5
-
15
-
-
85036565453
-
A controlled trial of bupropion SR for smoking cessation in patients with schizophrenia
-
San Francisco, USA
-
Evins EA, Goff DC, Shipman CO, Rigotti NA, Cather C. A controlled trial of bupropion SR for smoking cessation in patients with schizophrenia. Conference abstract of 156th Annual Meeting of the American Psychiatric Association: San Francisco, USA. 2003.
-
(2003)
Conference abstract of 156th Annual Meeting of the American Psychiatric Association
-
-
Evins, E.A.1
Goff, D.C.2
Shipman, C.O.3
Rigotti, N.A.4
Cather, C.5
-
16
-
-
34447542609
-
A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia
-
Evins A, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, et al. A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Journal of Clinical Psychopharmacology 2007;27(4):380-6.
-
(2007)
Journal of Clinical Psychopharmacology
, vol.27
, Issue.4
, pp. 380-386
-
-
Evins, A.1
Cather, C.2
Culhane, M.A.3
Birnbaum, A.4
Horowitz, J.5
Hsieh, E.6
-
17
-
-
85036575041
-
A placebo-controlled study of bupropion SR added to high dose nicotine replacement therapy for smoking cessation or reduction in schizophrenia (POS2-104)
-
Orlando, Florida, USA
-
Evins AE, Cather C, Culhane M, Birnbaum AS, Horowitz J, Hsieh E, et al. A placebo-controlled study of bupropion SR added to high dose nicotine replacement therapy for smoking cessation or reduction in schizophrenia (POS2-104). Conference abstract of Society for Research on Nicotine and Tobacco 12th Annual Meeting: Orlando, Florida, USA. 2006.
-
(2006)
Conference abstract of Society for Research on Nicotine and Tobacco 12th Annual Meeting
-
-
Evins, A.E.1
Cather, C.2
Culhane, M.3
Birnbaum, A.S.4
Horowitz, J.5
Hsieh, E.6
-
19
-
-
40949150642
-
A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses
-
Gallagher SM, Penn PE, Schindler E, Layne W. A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses. Journal of Psychoactive Drugs 2007;39(4):487-97.
-
(2007)
Journal of Psychoactive Drugs
, vol.39
, Issue.4
, pp. 487-497
-
-
Gallagher, S.M.1
Penn, P.E.2
Schindler, E.3
Layne, W.4
-
20
-
-
77951739789
-
Predictors of smoking cessation in schizophrenia: Analysis of data from three sequential controlled clinical trials
-
George TP, Hitsman B, Papandonatos GD, Sacco KA, Vessicchio JC, Dudas M, et al. Predictors of smoking cessation in schizophrenia: Analysis of data from three sequential controlled clinical trials. Neuropsychopharmacology 2004;29 Suppl 1:S103.
-
(2004)
Neuropsychopharmacology
, vol.29
, pp. S103
-
-
George, T.P.1
Hitsman, B.2
Papandonatos, G.D.3
Sacco, K.A.4
Vessicchio, J.C.5
Dudas, M.6
-
21
-
-
0033755585
-
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia
-
George TP, Ziedonis DM, Feingold A, Pepper W, Satterburg CA, Winkel J, et al. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry 2000;157:1835-42.
-
(2000)
American Journal of Psychiatry
, vol.157
, pp. 1835-1842
-
-
George, T.P.1
Ziedonis, D.M.2
Feingold, A.3
Pepper, W.4
Satterburg, C.A.5
Winkel, J.6
-
22
-
-
77951707257
-
Predictors of smoking cessation in schizophrenia: analysis of data from three sequential controlled clinical trials (PA5-3)
-
Phoenix, Arizona, USA
-
Sacco KA, Hitsman B, Papandonatos GD, Vessicchio JC, Dudas MM, Termine A, et al. Predictors of smoking cessation in schizophrenia: analysis of data from three sequential controlled clinical trials (PA5-3). Conference abstract of the Society for Research on Nicotine and Tobacco 10th Annual Meeting: Phoenix, Arizona, USA. 2004.
-
(2004)
Conference abstract of the Society for Research on Nicotine and Tobacco 10th Annual Meeting
-
-
Sacco, K.A.1
Hitsman, B.2
Papandonatos, G.D.3
Vessicchio, J.C.4
Dudas, M.M.5
Termine, A.6
-
23
-
-
77951739789
-
Predictors of smoking cessation in schizophrenia: Analysis of data from three sequential controlled clinical trials
-
George TP, Hitsman B, Papandonatos GD, Sacco KA, Vessicchio JC, Dudas M, et al. Predictors of smoking cessation in schizophrenia: Analysis of data from three sequential controlled clinical trials. Neuropsychopharmacology 2004;29 Suppl 1:S103.
-
(2004)
Neuropsychopharmacology
, vol.29
, pp. S103
-
-
George, T.P.1
Hitsman, B.2
Papandonatos, G.D.3
Sacco, K.A.4
Vessicchio, J.C.5
Dudas, M.6
-
24
-
-
0036642284
-
A placebo controlled trial of bupropion for smoking cessation in schizophrenia
-
George TP, Vessicchio JC, Termine A, Bregartner TA, Feingold A, Rounsaville BJ, et al. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry 2002;52(1):53-61.
-
(2002)
Biological Psychiatry
, vol.52
, Issue.1
, pp. 53-61
-
-
George, T.P.1
Vessicchio, J.C.2
Termine, A.3
Bregartner, T.A.4
Feingold, A.5
Rounsaville, B.J.6
-
25
-
-
77951707257
-
Predictors of smoking cessation in schizophrenia: analysis of data from three sequential controlled clinical trials (PA5-3)
-
Phoenix, Arizona, USA
-
Sacco KA, Hitsman B, Papandonatos GD, Vessicchio JC, Dudas MM, Termine A, et al. Predictors of smoking cessation in schizophrenia: analysis of data from three sequential controlled clinical trials (PA5-3). Conference abstract of the Society for Research on Nicotine and Tobacco 10th Annual Meeting: Phoenix, Arizona, USA. 2004.
-
(2004)
Conference abstract of the Society for Research on Nicotine and Tobacco 10th Annual Meeting
-
-
Sacco, K.A.1
Hitsman, B.2
Papandonatos, G.D.3
Vessicchio, J.C.4
Dudas, M.M.5
Termine, A.6
-
27
-
-
77951739789
-
Predictors of smoking cessation in schizophrenia: Analysis of data from three sequential controlled clinical trials
-
George TP, Hitsman B, Papandonatos GD, Sacco KA, Vessicchio JC, Dudas M, et al. Predictors of smoking cessation in schizophrenia: Analysis of data from three sequential controlled clinical trials. Neuropsychopharmacology 2004;29 Suppl. 1:S103.
-
(2004)
Neuropsychopharmacology
, vol.29
, pp. S103
-
-
George, T.P.1
Hitsman, B.2
Papandonatos, G.D.3
Sacco, K.A.4
Vessicchio, J.C.5
Dudas, M.6
-
28
-
-
36049036635
-
A randomized, double-blind, placebo-controlled trial of sustained-release bupropion combined with transdermal nicotine patch for smoking cessation in schizophrenia: Neuropsychological predictors of treatment outcome
-
George TP, Vessicchio J, Allen T, Weinberger A, Sacco KA. A randomized, double-blind, placebo-controlled trial of sustained-release bupropion combined with transdermal nicotine patch for smoking cessation in schizophrenia: Neuropsychological predictors of treatment outcome. Neuropsychopharmacology 2006;31 Suppl. 1:S254-5.
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. S254-S255
-
-
George, T.P.1
Vessicchio, J.2
Allen, T.3
Weinberger, A.4
Sacco, K.A.5
-
29
-
-
43049157766
-
A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia
-
George TP, Vessicchio JC, Sacco KA, Weinberger AH, Dudas MM, Allen TM, et al. A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biological Psychiatry 2008;63:1092-6.
-
(2008)
Biological Psychiatry
, vol.63
, pp. 1092-1096
-
-
George, T.P.1
Vessicchio, J.C.2
Sacco, K.A.3
Weinberger, A.H.4
Dudas, M.M.5
Allen, T.M.6
-
30
-
-
77951740151
-
Sustained-release bupropion combined with transdermal nicotine patch for smoking cessation in schizophrenia (SYM11C)
-
Austin, Texas, USA
-
George TP, Vessicchio JC, Weinberger AH, Sacco KA. Sustained-release bupropion combined with transdermal nicotine patch for smoking cessation in schizophrenia (SYM11C). Conference abstract of the Society for Research on Nicotine and Tobacco 13th Annual Meeting: Austin, Texas, USA. 2007.
-
(2007)
Conference abstract of the Society for Research on Nicotine and Tobacco 13th Annual Meeting
-
-
George, T.P.1
Vessicchio, J.C.2
Weinberger, A.H.3
Sacco, K.A.4
-
31
-
-
77951707257
-
Predictors of smoking cessation in schizophrenia: analysis of data from three sequential controlled clinical trials (PA5-3)
-
Phoenix, Arizona, USA
-
Sacco KA, Hitsman B, Papandonatos GD, Vessicchio JC, Dudas MM, Termine A, et al. Predictors of smoking cessation in schizophrenia: analysis of data from three sequential controlled clinical trials (PA5-3). Conference abstract of the Society for Research on Nicotine and Tobacco 10th Annual Meeting: Phoenix, Arizona, USA. 2004.
-
(2004)
Conference abstract of the Society for Research on Nicotine and Tobacco 10th Annual Meeting
-
-
Sacco, K.A.1
Hitsman, B.2
Papandonatos, G.D.3
Vessicchio, J.C.4
Dudas, M.M.5
Termine, A.6
-
32
-
-
77951281252
-
An efficacy analysis of bupropion for smoking cessation in schizophrenia
-
Li Jun, Zhang Tian-liang, Wang Bin, Li Xian-wei. An efficacy analysis of bupropion for smoking cessation in schizophrenia. Zhongguo Xinyao yu Linchuang Zazhi 2009;28(3):231-4.
-
(2009)
Zhongguo Xinyao yu Linchuang Zazhi
, vol.28
, Issue.3
, pp. 231-234
-
-
Li, J.1
Zhang, T.-L.2
Wang, B.3
Li, X.-W.4
-
33
-
-
85036516768
-
Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia
-
(accessed on 31/03/2010)
-
Weiner E. Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00554840 (accessed on 31/03/2010).
-
-
-
Weiner, E.1
-
34
-
-
79956066309
-
Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study
-
6459]
-
Weiner E, Buchholz A, Coffay A, Liu F, McMahon RP, Buchanan RW, et al. Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study. Schizophrenia Research 2011;129(1):94-5. [; 6459]
-
(2011)
Schizophrenia Research
, vol.129
, Issue.1
, pp. 94-95
-
-
Weiner, E.1
Buchholz, A.2
Coffay, A.3
Liu, F.4
McMahon, R.P.5
Buchanan, R.W.6
-
35
-
-
85036503844
-
A comparison of Bupropion SR and Placebo for Smoking Cessation
-
Colorado Springs, Colorado, USA
-
Weiner E, Ball MP, Buchanan R, Gold JM. A comparison of Bupropion SR and Placebo for Smoking Cessation. Conference abstract of the International Congress on Schizophrenia Research: Colorado Springs, Colorado, USA. 2007.
-
(2007)
Conference abstract of the International Congress on Schizophrenia Research
-
-
Weiner, E.1
Ball, M.P.2
Buchanan, R.3
Gold, J.M.4
-
36
-
-
84856249784
-
Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis
-
United States
-
Weiner E, Ball MP, Buchholz AS, Gold JM, Evins AE, McMahon RP, et al. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis. Journal of Clinical Psychiatry. United States, 2012; Vol. 73, issue 1:95-102. []
-
(2012)
Journal of Clinical Psychiatry
, vol.73
, Issue.1
, pp. 95-102
-
-
Weiner, E.1
Ball, M.P.2
Buchholz, A.S.3
Gold, J.M.4
Evins, A.E.5
McMahon, R.P.6
-
37
-
-
27744453317
-
A comparison of bupropion SR and placebo for smoking cessation in schizophrenia
-
Weiner E, Buchanan R, Gold J, Ball P, Bennett M. A comparison of bupropion SR and placebo for smoking cessation in schizophrenia. Schizophrenia Research 2003;60:305-6.
-
(2003)
Schizophrenia Research
, vol.60
, pp. 305-306
-
-
Weiner, E.1
Buchanan, R.2
Gold, J.3
Ball, P.4
Bennett, M.5
-
38
-
-
77952237532
-
No advantage for high dose compared to regular dose nicotine patch on short-term abstinence rates in schizophrenia (PA2-3)
-
Austin, Texas, USA
-
Williams JM, Gandhi KK, Foulds J, Steinberg M, Lou S, Masumova F, et al. No advantage for high dose compared to regular dose nicotine patch on short-term abstinence rates in schizophrenia (PA2-3). Conference abstract of the Society for Research on Nicotine and Tobacco 13th Annual Meeting: Austin, Texas, USA. 2007.
-
(2007)
Conference abstract of the Society for Research on Nicotine and Tobacco 13th Annual Meeting
-
-
Williams, J.M.1
Gandhi, K.K.2
Foulds, J.3
Steinberg, M.4
Lou, S.5
Masumova, F.6
-
39
-
-
36448953959
-
Psychosocial Treatments for Individuals with Schizophrenia and Tobacco Dependence
-
Steinberg ML, Williams J. Psychosocial Treatments for Individuals with Schizophrenia and Tobacco Dependence. Journal of Dual Diagnosis 2007;3(3/4):99-112.
-
(2007)
Journal of Dual Diagnosis
, vol.3
, Issue.3-4
, pp. 99-112
-
-
Steinberg, M.L.1
Williams, J.2
-
40
-
-
77952238720
-
Comparison of two intensities of tobacco dependence counselling in schizophrenia and schizoaffective disorder
-
Williams JM, Steinberg ML, Zimmermann MH, Gandhi KK, Stipelman B, Budsock PD, et al. Comparison of two intensities of tobacco dependence counselling in schizophrenia and schizoaffective disorder. Journal of Substance Abuse Treatment 2010; Vol. 38, issue 4:384-93. []
-
(2010)
Journal of Substance Abuse Treatment
, vol.38
, Issue.4
, pp. 384-393
-
-
Williams, J.M.1
Steinberg, M.L.2
Zimmermann, M.H.3
Gandhi, K.K.4
Stipelman, B.5
Budsock, P.D.6
-
41
-
-
36448931880
-
Behavioral Therapy Development for Smokers with Schizophrenia
-
Washington DC, USA
-
Ziedonis D, Williams J, Zimmermann M, Krejci J, Steinbery M, Foulds J, Violette N, Agatep B, Sawh L, Gaffney J. Behavioral Therapy Development for Smokers with Schizophrenia. Conference abstract of the 13th World Conference on Tobacco OR Health: Washington DC, USA. 2006.
-
(2006)
Conference abstract of the 13th World Conference on Tobacco OR Health
-
-
Ziedonis, D.1
Williams, J.2
Zimmermann, M.3
Krejci, J.4
Steinbery, M.5
Foulds, J.6
Violette, N.7
Agatep, B.8
Sawh, L.9
Gaffney, J.10
-
42
-
-
85036565714
-
Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder
-
(accessed on 31/03/2010)
-
Pfizer. Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder. www.clinicaltrials.gov/ct2/show/NCT00644969 (accessed on 31/03/2010).
-
-
-
-
43
-
-
84861838749
-
A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder
-
United States
-
Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, et al. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry. United States, 2012; Vol. 73, issue 5:654-60. []
-
(2012)
Journal of Clinical Psychiatry
, vol.73
, Issue.5
, pp. 654-660
-
-
Williams, J.M.1
Anthenelli, R.M.2
Morris, C.D.3
Treadow, J.4
Thompson, J.R.5
Yunis, C.6
-
44
-
-
85036540276
-
rTMS Effects on Smoking Cessation and Cognition in Schizophrenia
-
(accessed on 31/03/2010)
-
George T. rTMS Effects on Smoking Cessation and Cognition in Schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00736710 (accessed on 31/03/2010).
-
-
-
George, T.1
-
45
-
-
85041537086
-
A preliminary study of repetitive transcranial magnetic stimulation for smoking cessation in schizophrenia
-
ACNP, 5/12/2010-9/12/2010 Miami Beach, FL United States)
-
Wing V C, Bacher I, Daskalakis Z J, George T. A preliminary study of repetitive transcranial magnetic stimulation for smoking cessation in schizophrenia. Neuropsychopharmacology (Conference Proceedings of 49th Annual Conference of the American College of Neuropsychopharmacology, ACNP, 5/12/2010-9/12/2010 Miami Beach, FL United States). 2010; Vol. 35:S163.
-
(2010)
Neuropsychopharmacology (Conference Proceedings of 49th Annual Conference of the American College of Neuropsychopharmacology
, vol.35
, pp. S163
-
-
Wing, V.C.1
Bacher, I.2
Daskalakis, Z.J.3
George, T.4
-
46
-
-
84863776864
-
High frequency repetitive transcranial magnetic stimulation reduces tobacco craving in schizophrenia
-
Wing Victoria C, Bacher Ingrid, Wu Becky S, Daskalakis Zafiris J, George Tony P. High frequency repetitive transcranial magnetic stimulation reduces tobacco craving in schizophrenia. Schizophrenia Research 2012;139(1-3):264-6.
-
(2012)
Schizophrenia Research
, vol.139
, Issue.1-3
, pp. 264-266
-
-
Wing Victoria, C.1
Bacher, I.2
Wu Becky, S.3
Daskalakis Zafiris, J.4
George Tony, P.5
-
47
-
-
79953124060
-
A double-blind placebo-controlled trial of bupropion for smoking abstinence and cognition improvement in schizophrenia
-
Akbarpour F, Rezaei O, Khodaie-Ardakani MR, Sheikhvatan M, Goodarzi H, Dolatshahi B. A double-blind placebo-controlled trial of bupropion for smoking abstinence and cognition improvement in schizophrenia. Minerva Psichiatrica 2010; Vol. 51, issue 4:263-9. []
-
(2010)
Minerva Psichiatrica
, vol.51
, Issue.4
, pp. 263-269
-
-
Akbarpour, F.1
Rezaei, O.2
Khodaie-Ardakani, M.R.3
Sheikhvatan, M.4
Goodarzi, H.5
Dolatshahi, B.6
-
48
-
-
72049105573
-
Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia
-
Bloch B, Reshef A, Cohen T, Tafla A, Gathas S, Israel S, et al. Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia. Psychiatry Research 2010; Vol. 175, issue 1-2:38-42.
-
(2010)
Psychiatry Research
, vol.175
, Issue.1-2
, pp. 38-42
-
-
Bloch, B.1
Reshef, A.2
Cohen, T.3
Tafla, A.4
Gathas, S.5
Israel, S.6
-
49
-
-
85036557457
-
Nicotine Withdrawal and Replacement in Schizophrenia
-
San Diego, California, USA
-
Dalack GW, Becks L, Hill E, Pomerleau O, Meador-Woodruff JH. Nicotine Withdrawal and Replacement in Schizophrenia. Conference abstract from the 150th Annual Meeting of the American Psychiatric Association: San Diego, California, USA. 1997.
-
(1997)
Conference abstract from the 150th Annual Meeting of the American Psychiatric Association
-
-
Dalack, G.W.1
Becks, L.2
Hill, E.3
Pomerleau, O.4
Meador-Woodruff, J.H.5
-
50
-
-
85036498904
-
The effects of treated and untreated nicotine withdrawal on smokers with schizophrenia
-
Colorado Springs, Colorado, USA)
-
Dalack GW, Becks L, Hill E, Pomerleau O, Meador-Woodruff JH. The effects of treated and untreated nicotine withdrawal on smokers with schizophrenia. Schizophrenia Research (conference abstract from the 6th International Congress on Schizophrenia Research, Colorado Springs, Colorado, USA). 1997; Vol. 24:63.
-
(1997)
Schizophrenia Research (conference abstract from the 6th International Congress on Schizophrenia Research
, vol.24
, pp. 63
-
-
Dalack, G.W.1
Becks, L.2
Hill, E.3
Pomerleau, O.4
Meador-Woodruff, J.H.5
-
51
-
-
0033013136
-
Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia
-
Dalack GW, Becks L, Hill E, Pomerleau OF, Meador-Woodruff JH. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology 1999;21:195-202.
-
(1999)
Neuropsychopharmacology
, vol.21
, pp. 195-202
-
-
Dalack, G.W.1
Becks, L.2
Hill, E.3
Pomerleau, O.F.4
Meador-Woodruff, J.H.5
-
52
-
-
0033085918
-
Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia
-
Dalack GW, Meador-Woodruff JH. Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia. Nicotine & Tobacco Research 1999;1(1):53-7.
-
(1999)
Nicotine & Tobacco Research
, vol.1
, Issue.1
, pp. 53-57
-
-
Dalack, G.W.1
Meador-Woodruff, J.H.2
-
54
-
-
20444391347
-
A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia [Letter to the Editor]
-
Fatemi S, Stary J, Hatsukami D, Murphy S. A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia [Letter to the Editor]. Schizophrenia Research 2005;76(2-3):353-6.
-
(2005)
Schizophrenia Research
, vol.76
, Issue.2-3
, pp. 353-356
-
-
Fatemi, S.1
Stary, J.2
Hatsukami, D.3
Murphy, S.4
-
55
-
-
84856729395
-
Nonmedication smoking reduction program for inpatients with chronic schizophrenia: a randomized control design study
-
United States: Lippincott Williams and Wilkins (351 West Camden Street, Baltimore MD 21201-2436, United States)
-
Gelkopf M, Noam S, Rudinski D, Lerner A, Behrbalk P, Bleich A, et al. Nonmedication smoking reduction program for inpatients with chronic schizophrenia: a randomized control design study. Journal of Nervous and Mental Disease. United States: Lippincott Williams and Wilkins (351 West Camden Street, Baltimore MD 21201-2436, United States), 2012; Vol. 200, issue 2:142-6. []
-
(2012)
Journal of Nervous and Mental Disease
, vol.200
, Issue.2
, pp. 142-146
-
-
Gelkopf, M.1
Noam, S.2
Rudinski, D.3
Lerner, A.4
Behrbalk, P.5
Bleich, A.6
-
56
-
-
0025978518
-
Transdermal nicotine and smoking behavior in psychiatric patients
-
Hartman N, Leong GB, Glynn SM, Wilkins JN, Jarvik ME. Transdermal nicotine and smoking behavior in psychiatric patients. American Journal of Psychiatry 1991;148(3):374-5.
-
(1991)
American Journal of Psychiatry
, vol.148
, Issue.3
, pp. 374-375
-
-
Hartman, N.1
Leong, G.B.2
Glynn, S.M.3
Wilkins, J.N.4
Jarvik, M.E.5
-
57
-
-
85023776727
-
Engaging smokers with schizophrenia in treatment for tobacco dependence: A brief motivational interviewing intervention
-
3-B:
-
Steinberg ML. Engaging smokers with schizophrenia in treatment for tobacco dependence: A brief motivational interviewing intervention. Dissertation Abstracts International: Section B: The Sciences and Engineering 2003; Vol. 64, issue 3-B:1508.
-
(2003)
Dissertation Abstracts International: Section B: The Sciences and Engineering
, vol.64
, pp. 1508
-
-
Steinberg, M.L.1
-
58
-
-
3343015673
-
Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence
-
Steinberg ML, Ziedonis DM, Krejci JA, Brandon TH. Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. Journal of Consulting & Clinical Psychology 2004;72(4):723-8.
-
(2004)
Journal of Consulting & Clinical Psychology
, vol.72
, Issue.4
, pp. 723-728
-
-
Steinberg, M.L.1
Ziedonis, D.M.2
Krejci, J.A.3
Brandon, T.H.4
-
59
-
-
85036551148
-
Oral naltrexone treatment for alcohol dependence in schizophrenia is not effective for smoking cessation
-
Szombathyne-Meszaros Z, Dimmock J A, Ploutz-Snyder R, Batki S L. Oral naltrexone treatment for alcohol dependence in schizophrenia is not effective for smoking cessation. Alcoholism: Clinical and Experimental Research 2010;34(6):176A.
-
(2010)
Alcoholism: Clinical and Experimental Research
, vol.34
, Issue.6
, pp. 176A
-
-
Szombathyne-Meszaros, Z.1
Dimmock, J.A.2
Ploutz-Snyder, R.3
Batki, S.L.4
-
60
-
-
85036495973
-
Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
-
(accessed on 31/03/2010)
-
Tidey JW. Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00136760 (accessed on 31/03/2010).
-
-
-
Tidey, J.W.1
-
61
-
-
82955235583
-
Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia
-
Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Reid N. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology 2011; Vol. 217, issue 2:279-87. []
-
(2011)
Psychopharmacology
, vol.217
, Issue.2
, pp. 279-287
-
-
Tidey, J.W.1
Rohsenow, D.J.2
Kaplan, G.B.3
Swift, R.M.4
Reid, N.5
-
62
-
-
0032730108
-
Double-blind study of clozapine dose response in chronic schizophrenia
-
Simpson GM, Josiassen RC, Stanilla JK, de Leon J, Nair C, Abraham G, et al. Double-blind study of clozapine dose response in chronic schizophrenia. American Journal of Psychiatry 1999;156:1744-50.
-
(1999)
American Journal of Psychiatry
, vol.156
, pp. 1744-1750
-
-
Simpson, G.M.1
Josiassen, R.C.2
Stanilla, J.K.3
de Leon, J.4
Nair, C.5
Abraham, G.6
-
63
-
-
21244432047
-
Does clozapine decrease smoking?
-
de Leon J, Diaz FJ, Josiassen RC, Cooper TB, Simpson GM. Does clozapine decrease smoking?. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2005;29(5):757-62.
-
(2005)
Progress in Neuro-Psychopharmacology & Biological Psychiatry
, vol.29
, Issue.5
, pp. 757-762
-
-
de Leon, J.1
Diaz, F.J.2
Josiassen, R.C.3
Cooper, T.B.4
Simpson, G.M.5
-
65
-
-
83055160773
-
Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder
-
Hong LE, Thaker GK, McMahon RP, Summerfelt A, RachBeisel J, Fuller RL, Wonodi I, Buchanan RW, Myers C, Heishman SJ, Yang J, Nye Adrienne. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. Archives of General Psychiatry 2011;68(12):1195-1206.
-
(2011)
Archives of General Psychiatry
, vol.68
, Issue.12
, pp. 1195-1206
-
-
Hong, L.E.1
Thaker, G.K.2
McMahon, R.P.3
Summerfelt, A.4
RachBeisel, J.5
Fuller, R.L.6
Wonodi, I.7
Buchanan, R.W.8
Myers, C.9
Heishman, S.J.10
Yang, J.11
Nye, A.12
-
66
-
-
39049170052
-
Galantamine for the treatment of cognitive impairments in people with schizophrenia
-
Buchanan RW, Conley RR, Dickinson D, Ball MP, Feldman S, Gold J, et al. Galantamine for the treatment of cognitive impairments in people with schizophrenia. American Journal of Psychiatry 2008;165:82-9.
-
(2008)
American Journal of Psychiatry
, vol.165
, pp. 82-89
-
-
Buchanan, R.W.1
Conley, R.R.2
Dickinson, D.3
Ball, M.P.4
Feldman, S.5
Gold, J.6
-
67
-
-
47249094034
-
Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia
-
Kelly DL, McMahon RP, Weiner E, Boggs DL, Dickinson D, Conley RR, et al. Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia. Schizophrenia Research 2008;103(1-3):161-8.
-
(2008)
Schizophrenia Research
, vol.103
, Issue.1-3
, pp. 161-168
-
-
Kelly, D.L.1
McMahon, R.P.2
Weiner, E.3
Boggs, D.L.4
Dickinson, D.5
Conley, R.R.6
-
68
-
-
0028918837
-
Clozapine decreases smoking in patients with chronic schizophrenia
-
McEvoy J, Freudenreich O, McGee M, VanderZwaag C, Levin E, Rose J. Clozapine decreases smoking in patients with chronic schizophrenia. Biological Psychiatry 1995;37(8):550-2.
-
(1995)
Biological Psychiatry
, vol.37
, Issue.8
, pp. 550-552
-
-
McEvoy, J.1
Freudenreich, O.2
McGee, M.3
VanderZwaag, C.4
Levin, E.5
Rose, J.6
-
69
-
-
84965143587
-
Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia
-
(accessed on 31/03/2010)
-
Meszaros ZS. Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00727103 (accessed on 31/03/2010).
-
-
-
Meszaros, Z.S.1
-
70
-
-
84965125668
-
Varenicline treatment of alcohol and nicotine dependence in schizophrenia: Problems encountered in a pilot trial
-
Meszaros ZS, Abdul-Malak Y, Dimmock J A, Wang D, Batki S L. Varenicline treatment of alcohol and nicotine dependence in schizophrenia: Problems encountered in a pilot trial. American Journal on Addictions (Conference Proceedings of 22nd Annual Meeting and Symposium of the American Academy of Addiction Psychiatry, AAAP 8/12/2011-11/12/2011, Scottsdale, AZ United States). 2012; Vol. 21, issue 4:393-4.
-
(2012)
American Journal on Addictions (Conference Proceedings of 22nd Annual Meeting and Symposium of the American Academy of Addiction Psychiatry, AAAP 8/12/2011-11/12/2011, Scottsdale, AZ United States)
, vol.21
, Issue.4
, pp. 393-394
-
-
Meszaros, Z.S.1
Abdul-Malak, Y.2
Dimmock, J.A.3
Wang, D.4
Batki, S.L.5
-
71
-
-
58249107927
-
Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia
-
Sacco K A, Creeden C, Reutenauer E L, Vessicchio J C, Weinberger A H, George T P, et al. Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia. Schizophrenia Research 2009; Vol. 107, issue 2-3:332-3.
-
(2009)
Schizophrenia Research
, vol.107
, Issue.2-3
, pp. 332-333
-
-
Sacco, K.A.1
Creeden, C.2
Reutenauer, E.L.3
Vessicchio, J.C.4
Weinberger, A.H.5
George, T.P.6
-
72
-
-
84855866544
-
Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
-
Shim J C, Jung D U, Jung S S, Seo Y S, Cho D M, Lee J H, et al. Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial. Neuropsychopharmacology 2012;37(3):660-8.
-
(2012)
Neuropsychopharmacology
, vol.37
, Issue.3
, pp. 660-668
-
-
Shim, J.C.1
Jung, D.U.2
Jung, S.S.3
Seo, Y.S.4
Cho, D.M.5
Lee, J.H.6
-
73
-
-
84965095607
-
Varenicline treatment for smoking cessation in people with schizophrenia: A randomized double-blind placebo-controlled trial
-
Shim JC, Jung D, Oh M, Kong B, Ha T, Cho D, et al. Varenicline treatment for smoking cessation in people with schizophrenia: A randomized double-blind placebo-controlled trial. Schizophrenia Bulletin. 2011; Vol. 37:320-1. []
-
(2011)
Schizophrenia Bulletin.
, vol.37
, pp. 320-321
-
-
Shim, J.C.1
Jung, D.2
Oh, M.3
Kong, B.4
Ha, T.5
Cho, D.6
-
74
-
-
34548439468
-
A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type
-
Chengappa KNR, Kupfer DJ, Parepally H, John V, Basu R, Buttenfield J, et al. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type. Bipolar Disorder 2007;9(6):609-17.
-
(2007)
Bipolar Disorder
, vol.9
, Issue.6
, pp. 609-617
-
-
Chengappa, K.N.R.1
Kupfer, D.J.2
Parepally, H.3
John, V.4
Basu, R.5
Buttenfield, J.6
-
75
-
-
40949111085
-
Effects of topiramate on smoking in patients with schizoaffective disorder, bipolar type
-
Weinberger AH, George TP, Perkins KA, Chengappa KNR. Effects of topiramate on smoking in patients with schizoaffective disorder, bipolar type. Journal of Clinical Psychopharmacology 2008;28(2):247-8.
-
(2008)
Journal of Clinical Psychopharmacology
, vol.28
, Issue.2
, pp. 247-248
-
-
Weinberger, A.H.1
George, T.P.2
Perkins, K.A.3
Chengappa, K.N.R.4
-
76
-
-
67649351930
-
Effects of topiramate on smoking patients with schizoaffective disorder, bipolar type: Response to Khazaal and Zullino
-
Weinberger AH, George TP, Perkins KA, Chengappa KNR. Effects of topiramate on smoking patients with schizoaffective disorder, bipolar type: Response to Khazaal and Zullino. Journal of Clinical Psychopharmacology 2009;29:193-194.
-
(2009)
Journal of Clinical Psychopharmacology
, vol.29
, pp. 193-194
-
-
Weinberger, A.H.1
George, T.P.2
Perkins, K.A.3
Chengappa, K.N.R.4
-
77
-
-
79955140463
-
Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study
-
Allen MH, Debanné M, Lazignac C, Adam E, Dickinson LM, Damsa C. Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study. American Journal of Psychiatry 2011;168(4):395-9.
-
(2011)
American Journal of Psychiatry
, vol.168
, Issue.4
, pp. 395-399
-
-
Allen, M.H.1
Debanné, M.2
Lazignac, C.3
Adam, E.4
Dickinson, L.M.5
Damsa, C.6
-
78
-
-
85036580477
-
Effect of nicotine replacement on agitation and aggression in smokers with schizophrenia: a double blind, randomized placebo controlled pilot study
-
2009 May 16 21; San Francisco, CA. [30292]
-
Damsa C, Lazignac C, Adam E, Virgillito S, Allen MH. Effect of nicotine replacement on agitation and aggression in smokers with schizophrenia: a double blind, randomized placebo controlled pilot study. Proceedings of the 162nd Annual Meeting of the American Psychiatric Association; 2009 May 16 21; San Francisco, CA. 2009. [; 30292]
-
(2009)
Proceedingsof the 162nd Annual Meeting of the American Psychiatric Association
-
-
Damsa, C.1
Lazignac, C.2
Adam, E.3
Virgillito, S.4
Allen, M.H.5
-
79
-
-
78651514903
-
Smoking Cessation in Women With Severe Mental Illness: Exploring the Role of Exercise as an Adjunct Treatment
-
Arbour-Nicitopoulos K P, Faulkner G E, Cohn T A, Selby P. Smoking Cessation in Women With Severe Mental Illness: Exploring the Role of Exercise as an Adjunct Treatment. Archives of Psychiatric Nursing 2011;25(1):43-52.
-
(2011)
Archives of Psychiatric Nursing
, vol.25
, Issue.1
, pp. 43-52
-
-
Arbour-Nicitopoulos, K.P.1
Faulkner, G.E.2
Cohn, T.A.3
Selby, P.4
-
80
-
-
80755128432
-
A pilot study examining the acute effects of exercise on cigarette cravings and affect among individuals with serious mental illness
-
Arbour-Nicitopoulos K P, Faulkner G E, Hsin A, Selby P. A pilot study examining the acute effects of exercise on cigarette cravings and affect among individuals with serious mental illness. Mental Health and Physical Activity 2011;4(2):89-94.
-
(2011)
Mental Health and Physical Activity
, vol.4
, Issue.2
, pp. 89-94
-
-
Arbour-Nicitopoulos, K.P.1
Faulkner, G.E.2
Hsin, A.3
Selby, P.4
-
81
-
-
82855175215
-
Smoking, quitting, and psychiatric disease: a review
-
United States
-
Aubin HJ, Rollema H, Svensson TH, Winterer G. Smoking, quitting, and psychiatric disease: a review. Neuroscience and Biobehavioral Reviews. United States, 2012; Vol. 36, issue 1:271 // 284. []
-
(2012)
Neuroscience and Biobehavioral Reviews
, vol.36
, Issue.1
, pp. 271-284
-
-
Aubin, H.J.1
Rollema, H.2
Svensson, T.H.3
Winterer, G.4
-
82
-
-
75349090897
-
Smoking and schizophrenia: Treatment approaches within primary care
-
Baker Amanda L, Lubman Dan I, Hides Leanne. Smoking and schizophrenia: Treatment approaches within primary care. Primary Psychiatry 2010;17(1):49-54.
-
(2010)
Primary Psychiatry
, vol.17
, Issue.1
, pp. 49-54
-
-
Baker Amanda, L.1
Lubman Dan, I.2
Hides, L.3
-
83
-
-
77953316403
-
Smoking cessation in severe mental illness: What works?
-
Banham Lindsay, Gilbody Simon. Smoking cessation in severe mental illness: What works?. Addiction 2010;105(7):1176-89.
-
(2010)
Addiction
, vol.105
, Issue.7
, pp. 1176-1189
-
-
Banham, L.1
Gilbody, S.2
-
84
-
-
4544374306
-
Effects of motivational interviewing on smoking cessation in adolescents with psychiatric disorders
-
Brown RA, Ramsey SE, Strong DR, Myers MG, Kahler CW, Lejuez CW, et al. Effects of motivational interviewing on smoking cessation in adolescents with psychiatric disorders. Tobacco Control 2003;12 Suppl 4:iv3-iv10.
-
(2003)
Tobacco Control
, vol.12
, pp. 3-10
-
-
Brown, R.A.1
Ramsey, S.E.2
Strong, D.R.3
Myers, M.G.4
Kahler, C.W.5
Lejuez, C.W.6
-
85
-
-
79953692715
-
An Electronic Decision Support System to Motivate People With Severe Mental Illnesses to Quit Smoking
-
Brunette M F, Ferron J C, McHugo G J, Davis K E, Devitt T S, Wilkness S M, et al. An Electronic Decision Support System to Motivate People With Severe Mental Illnesses to Quit Smoking. Psychiatric Services 2011;62(4):360-6.
-
(2011)
Psychiatric Services
, vol.62
, Issue.4
, pp. 360-366
-
-
Brunette, M.F.1
Ferron, J.C.2
McHugo, G.J.3
Davis, K.E.4
Devitt, T.S.5
Wilkness, S.M.6
-
86
-
-
79961117860
-
A systematic review and meta-analysis of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups
-
Bryant J, Bonevski B, Paul C, McElduff P, Attia J. A systematic review and meta-analysis of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups. Addiction 2011;106 (9):1568-85.
-
(2011)
Addiction
, vol.106
, Issue.9
, pp. 1568-1585
-
-
Bryant, J.1
Bonevski, B.2
Paul, C.3
McElduff, P.4
Attia, J.5
-
87
-
-
85036581141
-
Varenicline as a smoking cessation aid in schizophrenia patients: Effects on smoking behavior and reward sensitivity
-
1
-
Dutra SJ, Stoeckel LE, Carlini SV, Pizzagalli DA, Evins AE. Varenicline as a smoking cessation aid in schizophrenia patients: Effects on smoking behavior and reward sensitivity. Biological Psychiatry 2011; Vol. 69, issue 9 SUPPL. 1:280S. []
-
(2011)
Biological Psychiatry
, vol.69
, Issue.9
, pp. 280S
-
-
Dutra, S.J.1
Stoeckel, L.E.2
Carlini, S.V.3
Pizzagalli, D.A.4
Evins, A.E.5
-
88
-
-
84856676758
-
Varenicline as a smoking cessation aid in schizophrenia: Effects on smoking behavior and reward sensitivity
-
Dutra Sunny J, Stoeckel Luke E, Carlini Sara V, Pizzagalli Diego A, Evins AE, Dutra SJ, et al. Varenicline as a smoking cessation aid in schizophrenia: Effects on smoking behavior and reward sensitivity. Psychopharmacology 2012; Vol. 219, issue 1:25-34. []
-
(2012)
Psychopharmacology
, vol.219
, Issue.1
, pp. 25-34
-
-
Dutra Sunny, J.1
Stoeckel Luke, E.2
Carlini Sara, V.3
Pizzagalli Diego, A.4
Evins, A.E.5
Dutra, S.J.6
-
89
-
-
85036581489
-
A Group Intervention which assists patients with dual diagnosis reduce their tobacco use
-
In: Abelian ME editor(s). Hauppauge, NY: Nova Science Publishers
-
Kisely SR, Preston NJ. A Group Intervention which assists patients with dual diagnosis reduce their tobacco use. In: Abelian ME editor(s). Trends in psychotherapy research. Hauppauge, NY: Nova Science Publishers, 2006:141-59.
-
(2006)
Trends in psychotherapy research
, pp. 141-159
-
-
Kisely, S.R.1
Preston, N.J.2
-
90
-
-
77952237734
-
Smoking outcome by psychiatric history after behavioral and varenicline treatment
-
McClure J B, Swan G E, Catz S L, Jack L, Javitz H, McAfee T, et al. Smoking outcome by psychiatric history after behavioral and varenicline treatment. Journal of Substance Abuse Treatment 2010;38(4):394-402.
-
(2010)
Journal of Substance Abuse Treatment
, vol.38
, Issue.4
, pp. 394-402
-
-
McClure, J.B.1
Swan, G.E.2
Catz, S.L.3
Jack, L.4
Javitz, H.5
McAfee, T.6
-
91
-
-
0033027553
-
Smoking and therapeutic response to clozapine in patients with schizophrenia
-
McEvoy JP, Freudenreich O, Wilson WH. Smoking and therapeutic response to clozapine in patients with schizophrenia. Biological Psychiatry 1999;46:125-9.
-
(1999)
Biological Psychiatry
, vol.46
, pp. 125-129
-
-
McEvoy, J.P.1
Freudenreich, O.2
Wilson, W.H.3
-
92
-
-
71649095211
-
Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behaviour, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study
-
McKee SA, Weinberger AH, Harrison ELR, Coppola S, George TP. Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behaviour, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study. Schizophrenia Research 2009;115:317-24.
-
(2009)
Schizophrenia Research
, vol.115
, pp. 317-324
-
-
McKee, S.A.1
Weinberger, A.H.2
Harrison, E.L.R.3
Coppola, S.4
George, T.P.5
-
93
-
-
82655180881
-
Smoking reduction for persons with mental illnesses: 6-month results from community-based interventions
-
Morris C D, Waxmonsky J A, May M G, Tinkelman D G, Dickinson M, Giese A A, et al. Smoking reduction for persons with mental illnesses: 6-month results from community-based interventions. Community Mental Health Journal 2011;47(6):694-702.
-
(2011)
Community Mental Health Journal
, vol.47
, Issue.6
, pp. 694-702
-
-
Morris, C.D.1
Waxmonsky, J.A.2
May, M.G.3
Tinkelman, D.G.4
Dickinson, M.5
Giese, A.A.6
-
94
-
-
84861412607
-
Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week Open-Label Trial
-
Pachas G N, Cather C, Pratt S I, Hoeppner B, Nino J, Carlini S V, et al. Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week Open-Label Trial. Journal of Dual Diagnosis 2012;8(2):117-25.
-
(2012)
Journal of Dual Diagnosis
, vol.8
, Issue.2
, pp. 117-125
-
-
Pachas, G.N.1
Cather, C.2
Pratt, S.I.3
Hoeppner, B.4
Nino, J.5
Carlini, S.V.6
-
95
-
-
0031779583
-
Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: a feasibility study
-
Roll JM, Higgins ST, Steingard S, McGinley M. Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: a feasibility study. Experimental & Clinical Psychopharmacology 1998;6(2):157-61.
-
(1998)
Experimental & Clinical Psychopharmacology
, vol.6
, Issue.2
, pp. 157-161
-
-
Roll, J.M.1
Higgins, S.T.2
Steingard, S.3
McGinley, M.4
-
96
-
-
77954611225
-
A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
-
Shiina A, Shirayama Y, Niitsu T, Hashimoto T, Yoshida T, Hasegawa T, et al. A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia. Annals of General Psychiatry 2010;9:27.
-
(2010)
Annals of General Psychiatry
, vol.9
, pp. 27
-
-
Shiina, A.1
Shirayama, Y.2
Niitsu, T.3
Hashimoto, T.4
Yoshida, T.5
Hasegawa, T.6
-
97
-
-
85047682250
-
Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia
-
Tidey JW, O'Neill SC, Higgins ST. Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Experimental & Clinical Psychopharmacology 2002;10(3):241-7.
-
(2002)
Experimental & Clinical Psychopharmacology
, vol.10
, Issue.3
, pp. 241-247
-
-
Tidey, J.W.1
O'Neill, S.C.2
Higgins, S.T.3
-
99
-
-
0035065999
-
Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia
-
Weiner E, Ball MP, Summerfelt A, Gold J, Buchanan RW. Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. American Journal of Psychiatry 2001;158(4):635-7.
-
(2001)
American Journal of Psychiatry
, vol.158
, Issue.4
, pp. 635-637
-
-
Weiner, E.1
Ball, M.P.2
Summerfelt, A.3
Gold, J.4
Buchanan, R.W.5
-
100
-
-
85036506234
-
Increasing motivation to stop smoking among persons with schizophrenia and other chronic mental illnesses
-
8-B
-
Wells ME. Increasing motivation to stop smoking among persons with schizophrenia and other chronic mental illnesses. Dissertation Abstracts International: Section B: The Sciences and Engineering 2003; Vol. 63, issue 8-B.
-
(2003)
Dissertation Abstracts International: Section B: The Sciences and Engineering
, vol.63
-
-
Wells, M.E.1
-
101
-
-
85036542809
-
The impact of smoking cessation programs on schizophrenic patients' smoking behaviors [abstract]
-
Chen R, Ku C, Chou K, Shen C. The impact of smoking cessation programs on schizophrenic patients' smoking behaviors [abstract]. American Journal of Respiratory and Critical Care Medicine 2002;165(8 Suppl):A309.
-
(2002)
American Journal of Respiratory and Critical Care Medicine
, vol.165
, Issue.8
, pp. A309
-
-
Chen, R.1
Ku, C.2
Chou, K.3
Shen, C.4
-
102
-
-
1242323583
-
The impact of smoking cessation programs on smoking-related health belief and rate of quit-smoking among schizophrenic patients
-
Chen R, Ku C-H, Lu R-B, Chou K-R. The impact of smoking cessation programs on smoking-related health belief and rate of quit-smoking among schizophrenic patients. Journal of Medical Sciences 2002;22(5):215-20.
-
(2002)
Journal of Medical Sciences
, vol.22
, Issue.5
, pp. 215-220
-
-
Chen, R.1
Ku, C.-H.2
Lu, R.-B.3
Chou, K.-R.4
-
103
-
-
1242351546
-
The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia
-
Chou KR, Chen R, Lee JF, Ku CH, Lu RB. The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. International Journal of Nursing Studies 2004;41(3):321-30.
-
(2004)
International Journal of Nursing Studies
, vol.41
, Issue.3
, pp. 321-330
-
-
Chou, K.R.1
Chen, R.2
Lee, J.F.3
Ku, C.H.4
Lu, R.B.5
-
104
-
-
85036506390
-
Healthy lifestyle intervention for cardiovascular disease risk reduction among smokers with psychotic disorders
-
(accessed on 11/4/2010)
-
Baker A. Healthy lifestyle intervention for cardiovascular disease risk reduction among smokers with psychotic disorders. www.anzctr.org.au/trial_view.aspx?ID=308232 (accessed on 11/4/2010).
-
-
-
Baker, A.1
-
105
-
-
79952586752
-
Healthy lifestyle intervention for people with severe mental disorders
-
Baker A L, Kay-Lambkin F J, Richmond R, Filia S, Castle D, Williams J, et al. Healthy lifestyle intervention for people with severe mental disorders. Mental Health and Substance Use: Dual Diagnosis 2010;4 (2):144-57.
-
(2010)
Mental Health and Substance Use: Dual Diagnosis
, vol.4
, Issue.2
, pp. 144-157
-
-
Baker, A.L.1
Kay-Lambkin, F.J.2
Richmond, R.3
Filia, S.4
Castle, D.5
Williams, J.6
-
106
-
-
78650799024
-
Study protocol: a randomised controlled trial investigating the effect of a healthy lifestyle intervention for people with severe mental disorders
-
Baker A, Kay-Lambkin FJ, Richmond R, Filia S, Castle D, Williams J, et al. Study protocol: a randomised controlled trial investigating the effect of a healthy lifestyle intervention for people with severe mental disorders. BMC Public Health 2011; Vol. 11, issue 1:10.
-
(2011)
BMC Public Health
, vol.11
, Issue.1
, pp. 10
-
-
Baker, A.1
Kay-Lambkin, F.J.2
Richmond, R.3
Filia, S.4
Castle, D.5
Williams, J.6
-
107
-
-
85036555191
-
Randomised controlled trial of a healthy lifestyles intervention to reduce cardiovascular disease (CVD) risk among smokers with psychosis: Interim results
-
Filia S, Baker A, Richmond R, Kay-Lambkin F, Castle D, Williams J, et al. Randomised controlled trial of a healthy lifestyles intervention to reduce cardiovascular disease (CVD) risk among smokers with psychosis: Interim results. Australian and New Zealand Journal of Psychiatry 2010;44:A31-A32. []
-
(2010)
Australian and New Zealand Journal of Psychiatry
, vol.44
, pp. A31-A32
-
-
Filia, S.1
Baker, A.2
Richmond, R.3
Kay-Lambkin, F.4
Castle, D.5
Williams, J.6
-
108
-
-
85036567656
-
Smoking cessation for veterans with severe and persistent mental illness
-
(accessed on 20/7/12)
-
Dixon L B, Potts W. Smoking cessation for veterans with severe and persistent mental illness. www.clinicaltrials.gov/ct2/show/NCT00960375 (accessed on 20/7/12).
-
-
-
Dixon, L.B.1
Potts, W.2
-
109
-
-
85036591060
-
A study of Varenicline for Prevention of Relapse to Smoking in Patients with Schizophrenia or Bipolar Disorder (SCRP)
-
(accessed on 12/11/2012)
-
Evins AE. A study of Varenicline for Prevention of Relapse to Smoking in Patients with Schizophrenia or Bipolar Disorder (SCRP). www.clinicaltrials.gov/ct2/show/NCT00621777 (accessed on 12/11/2012).
-
-
-
Evins, A.E.1
-
110
-
-
85036580089
-
Varenicline and smoking cessation in schizophrenia (VSCS)
-
accessed on 20/7/12
-
Fatemi SH. Varenicline and smoking cessation in schizophrenia (VSCS). http://www.clinicaltrials.gov/ct2/show/NCT01111149 (accessed on 20/7/12).
-
-
-
Fatemi, S.H.1
-
111
-
-
85036581076
-
Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia
-
(accessed on 31/03/2010)
-
Josiassen RJ. Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00231101 (accessed on 31/03/2010).
-
-
-
Josiassen, R.J.1
-
112
-
-
85036532372
-
Contingency Management for Smoking Cessation Among Veterans With Psychotic Disorders
-
(accessed on 12/11/2012)
-
Saxon AJ. Contingency Management for Smoking Cessation Among Veterans With Psychotic Disorders. www.clinicaltrials.gov/ct2/show/NCT00508560 (accessed on 12/11/2012).
-
-
-
Saxon, A.J.1
-
113
-
-
85036538893
-
Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
-
(accessed on 12/11/2012)
-
Smith RC. Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors. www.clinicaltrials.gov/ct2/show/NCT00802919 (accessed on 12/11/2012).
-
-
-
Smith, R.C.1
-
114
-
-
85036582179
-
The effect of an integrated smoking care program on the reduction and abstinence of smoking in mental health inpatients following discharge from hospital
-
(accessed on 16/11/2012)
-
The effect of an integrated smoking care program on the reduction and abstinence of smoking in mental health inpatients following discharge from hospital. http://www.anzctr.org.au/trial_view.aspx?ID=83938 (accessed on 16/11/2012).
-
-
-
-
115
-
-
79960555497
-
A randomised controlled trial linking mental health inpatients to community smoking cessation supports: a study protocol
-
Stockings EA, Bowman JA, Wiggers J, Baker AL, Terry M, Clancy R, et al. A randomised controlled trial linking mental health inpatients to community smoking cessation supports: a study protocol. BMC Public Health 2011;11:570.
-
(2011)
BMC Public Health
, vol.11
, pp. 570
-
-
Stockings, E.A.1
Bowman, J.A.2
Wiggers, J.3
Baker, A.L.4
Terry, M.5
Clancy, R.6
-
116
-
-
85036588023
-
Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia
-
accessed on 12/11/2012
-
Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia. http://www.clinicaltrials.gov/ct2/show/NCT01010477 (accessed on 12/11/2012).
-
-
-
-
117
-
-
0031751031
-
Schizophrenia, sensory gating, and nicotinic receptors
-
Adler LE, Olincy A, Waldo M, Harris JG, Griffith J, Stevens K, et al. Schizophrenia, sensory gating, and nicotinic receptors. Schizophrenia Bulletin 1998;24(2):189-202.
-
(1998)
Schizophrenia Bulletin
, vol.24
, Issue.2
, pp. 189-202
-
-
Adler, L.E.1
Olincy, A.2
Waldo, M.3
Harris, J.G.4
Griffith, J.5
Stevens, K.6
-
118
-
-
84870481181
-
-
4th Edition. Washington, DC: American Psychiatric Association
-
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder. 4th Edition. Washington, DC: American Psychiatric Association, 1994.
-
(1994)
Diagnostic and Statistical Manual of Mental Disorder
-
-
-
119
-
-
62649107855
-
Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption
-
Amiaz R, Levy D, Vainiger D, Grunhaus L, Zangen A. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction 2009;104(4):653-660.
-
(2009)
Addiction
, vol.104
, Issue.4
, pp. 653-660
-
-
Amiaz, R.1
Levy, D.2
Vainiger, D.3
Grunhaus, L.4
Zangen, A.5
-
121
-
-
73949137552
-
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
-
Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, et al. The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements. Schizophrenia Bulletin 2010;36(1):71-93.
-
(2010)
Schizophrenia Bulletin
, vol.36
, Issue.1
, pp. 71-93
-
-
Buchanan, R.W.1
Kreyenbuhl, J.2
Kelly, D.L.3
Noel, J.M.4
Boggs, D.L.5
Fischer, B.A.6
-
122
-
-
79955667672
-
Competitions and incentives for smoking cessation
-
Cahill K, Perera R. Competitions and incentives for smoking cessation. Cochrane Database of Systematic Reviews 2011, Issue 4. [DOI: 10.1002/14651858.CD004307.pub4]
-
(2011)
Cochrane Database of Systematic Reviews
, Issue.4
-
-
Cahill, K.1
Perera, R.2
-
124
-
-
84865758663
-
Does Varenicline Worsen Psychiatric Symptoms in Patients With Schizophrenia or Schizoaffective Disorder? A Review of Published Studies
-
Cerimele JM, Durango A. Does Varenicline Worsen Psychiatric Symptoms in Patients With Schizophrenia or Schizoaffective Disorder? A Review of Published Studies. Journal of Clinical Psychiatry 2012;73(8):e1039-1047.
-
(2012)
Journal of Clinical Psychiatry
, vol.73
, Issue.8
-
-
Cerimele, J.M.1
Durango, A.2
-
125
-
-
0037560389
-
Balancing benefits and harms in health care
-
Cuervo LG, Clarke M. Balancing benefits and harms in health care. British Medical Journal 2003;327(7406):65-66.
-
(2003)
British Medical Journal
, vol.327
, Issue.7406
, pp. 65-66
-
-
Cuervo, L.G.1
Clarke, M.2
-
126
-
-
57349128802
-
Predictors of early abstinence in smokers with schizophrenia
-
Culhane MA, Schoenfeld DA, Barr RS, Cather C, Deckersbach T, Freudenreich O, et al. Predictors of early abstinence in smokers with schizophrenia. Journal of Clinical Psychiatry 2008;69(11):1743-50.
-
(2008)
Journal of Clinical Psychiatry
, vol.69
, Issue.11
, pp. 1743-1750
-
-
Culhane, M.A.1
Schoenfeld, D.A.2
Barr, R.S.3
Cather, C.4
Deckersbach, T.5
Freudenreich, O.6
-
127
-
-
20444463577
-
A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors
-
de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research 2005;76(2/3):135-57.
-
(2005)
Schizophrenia Research
, vol.76
, Issue.2-3
, pp. 135-157
-
-
de Leon, J.1
Diaz, F.J.2
-
128
-
-
0034958715
-
Smoking in patients receiving psychotropic medications: A pharmacokinetic perspective
-
Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: A pharmacokinetic perspective. CNS Drugs 2001;15(6):469-94.
-
(2001)
CNS Drugs
, vol.15
, Issue.6
, pp. 469-494
-
-
Desai, H.D.1
Seabolt, J.2
Jann, M.W.3
-
129
-
-
0033105779
-
Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes
-
Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophrenia Research 1999;35 Suppl:S93-S100.
-
(1999)
Schizophrenia Research
, vol.35
, pp. S93-S100
-
-
Dixon, L.1
-
131
-
-
0042512428
-
High-frequency repetitive transcranial magnetic stimulation decreases cigarette smoking
-
Eichhammer P, Johann M, Kharraz A, Binder H, Pittrow D, Wodarz N, Hajak G. High-frequency repetitive transcranial magnetic stimulation decreases cigarette smoking. Journal of Clinical Psychiatry 2003;64(8):951-953.
-
(2003)
Journal of Clinical Psychiatry
, vol.64
, Issue.8
, pp. 951-953
-
-
Eichhammer, P.1
Johann, M.2
Kharraz, A.3
Binder, H.4
Pittrow, D.5
Wodarz, N.6
Hajak, G.7
-
132
-
-
0022206182
-
Effects of smoking on fluphenazine clearance in psychiatric inpatients
-
Ereshefsky L, Jann MW, Saklad SR, Davis CM, Richards AL, Burch NR. Effects of smoking on fluphenazine clearance in psychiatric inpatients. Biological Psychiatry 1985;20:329-332.
-
(1985)
Biological Psychiatry
, vol.20
, pp. 329-332
-
-
Ereshefsky, L.1
Jann, M.W.2
Saklad, S.R.3
Davis, C.M.4
Richards, A.L.5
Burch, N.R.6
-
133
-
-
67649261299
-
Public Health Advisory: Important Information on Chantix (varenicline)
-
(accessed on 30/11/12)
-
US Food, Drug Administration. Public Health Advisory: Important Information on Chantix (varenicline). http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm051136.htm (accessed on 30/11/12).
-
-
-
-
134
-
-
84455194972
-
FDA drug safety communication: safety review update of Chantix (varenicline) and risk of neuropsychiatric adverse events
-
(accessed 30/11/2012) October
-
US Food, Drug Administration. [FDA drug safety communication: safety review update of Chantix (varenicline) and risk of neuropsychiatric adverse events.]. http://www.fda.gov/Drugs/DrugSafety/ucm276737.htm (accessed 30/11/2012) October 2011.
-
(2011)
-
-
-
135
-
-
43249084589
-
-
United States Department of Health and Human Services
-
Fiore M, Jaén C, Baker T, Bailey W, Benowitz NL, Curry S, et al. Treating tobacco use and dependence: 2008 Update - Clinical Practice Guideline. United States Department of Health and Human Services, 2008.
-
(2008)
Treating tobacco use and dependence: 2008 Update - Clinical Practice Guideline
-
-
Fiore, M.1
Jaén, C.2
Baker, T.3
Bailey, W.4
Benowitz, N.L.5
Curry, S.6
-
136
-
-
34548071446
-
Exacerbation of schizophrenia by varenicline
-
Freedman R. Exacerbation of schizophrenia by varenicline. American Journal of Psychiatry 2007;164:1269.
-
(2007)
American Journal of Psychiatry
, vol.164
, pp. 1269
-
-
Freedman, R.1
-
137
-
-
85013798232
-
Prescribing Information (Wellbutrin XL - bupropion hydrochloride extended-release tablets)
-
Prescribing Information (Wellbutrin XL - bupropion hydrochloride extended-release tablets). http://us.gsk.com/products/assets/us_wellbutrinXL.pdf 2008.
-
(2008)
-
-
-
138
-
-
0026800996
-
Cigarette smoking in schizophrenia: Relaitonship to psychopathology and medication side effects
-
Goff DC, Henderson DC, Amico E. Cigarette smoking in schizophrenia: Relaitonship to psychopathology and medication side effects. American Journal of Psychiatry 1992;149(9):1189-94.
-
(1992)
American Journal of Psychiatry
, vol.149
, Issue.9
, pp. 1189-1194
-
-
Goff, D.C.1
Henderson, D.C.2
Amico, E.3
-
139
-
-
70449392796
-
Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database
-
Gunnell D, Irvine D, Wise L, Davies C, Martin RM. Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. British Medical Journal 2009;339:b3805.
-
(2009)
British Medical Journal
, vol.339
-
-
Gunnell, D.1
Irvine, D.2
Wise, L.3
Davies, C.4
Martin, R.M.5
-
140
-
-
0026848643
-
Operant conditioning of activities of daily living on a psychogeriatric ward: A simple method
-
Gustafson R. Operant conditioning of activities of daily living on a psychogeriatric ward: A simple method. Psychological Reports 1992;70:603-7.
-
(1992)
Psychological Reports
, vol.70
, pp. 603-607
-
-
Gustafson, R.1
-
141
-
-
80051599762
-
Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand
-
Harrison-Woolrych M, Ashton J. Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand. Drug Safety 2011;34(9):763-772.
-
(2011)
Drug Safety
, vol.34
, Issue.9
, pp. 763-772
-
-
Harrison-Woolrych, M.1
Ashton, J.2
-
143
-
-
85100415918
-
Cochrane Handbook for Systematic Reviews of Interventions,5.1.0 [updated March 2011]
-
The Cochrane Collaboration
-
Higgins JPT, Green S [eds]. Cochrane Handbook for Systematic Reviews of Interventions, 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
-
(2011)
-
-
Higgins, J.P.T.1
Green, S.2
-
144
-
-
23444434489
-
The feasibility of smoking reduction: an update
-
Hughes JR, Carpenter MJ. The feasibility of smoking reduction: an update. Addiction 2005;100:1074-89.
-
(2005)
Addiction
, vol.100
, pp. 1074-1089
-
-
Hughes, J.R.1
Carpenter, M.J.2
-
145
-
-
33751583834
-
Does smoking reduction increase future cessation and decrease disease risk? A qualitative review
-
Hughes JR, Carpenter MJ. Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine & Tobacco Research 2006;8(6):739-49.
-
(2006)
Nicotine & Tobacco Research
, vol.8
, Issue.6
, pp. 739-749
-
-
Hughes, J.R.1
Carpenter, M.J.2
-
147
-
-
31344443894
-
Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function
-
Johnson BA. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function. CNS Drugs 2005;19:873-896.
-
(2005)
CNS Drugs
, vol.19
, pp. 873-896
-
-
Johnson, B.A.1
-
148
-
-
66249112505
-
Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study
-
Kasliwal R, Wilton LV, Shakir SA. Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study. Drug Safety 2009;32(6):499-507.
-
(2009)
Drug Safety
, vol.32
, Issue.6
, pp. 499-507
-
-
Kasliwal, R.1
Wilton, L.V.2
Shakir, S.A.3
-
149
-
-
0032746548
-
Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland
-
Kelly C, McCreadie RG. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. American Journal of Psychiatry 1999;156(11):1751-7.
-
(1999)
American Journal of Psychiatry
, vol.156
, Issue.11
, pp. 1751-1757
-
-
Kelly, C.1
McCreadie, R.G.2
-
150
-
-
79959782027
-
Cigarette Smoking and Mortality Risk in People with Schizophrenia
-
Kelly DL, McMahon RP, Wehring HJ, Liu F, Mackowick KM, Boggs DL, Warren KR, Feldman S, Shim J-C, Love RC, Dixon L. Cigarette Smoking and Mortality Risk in People with Schizophrenia. Schizophrenia Bulletin 2011;37(4):832-838. [DOI: 10.1093/schbul/sbp152]
-
(2011)
Schizophrenia Bulletin
, vol.37
, Issue.4
, pp. 832-838
-
-
Kelly, D.L.1
McMahon, R.P.2
Wehring, H.J.3
Liu, F.4
Mackowick, K.M.5
Boggs, D.L.6
Warren, K.R.7
Feldman, S.8
Shim, J.-C.9
Love, R.C.10
Dixon, L.11
-
151
-
-
84860113644
-
Perception of Smoking Risks and Motivatin to Quit Among Nontreatment-Seeking Smokers With and Without Schizophrenia
-
Kelly DL, Raley HG, Lo S, Wright K, Liu F, McMahon RP, Moolchan ET, Feldman S, Richardson CM, Wehring HJ, Heishman SJ. Perception of Smoking Risks and Motivatin to Quit Among Nontreatment-Seeking Smokers With and Without Schizophrenia. Schizophrenia Bulletin 2012;38(3):543-551. [DOI: 10.1093/schbul/sbq124]
-
(2012)
Schizophrenia Bulletin
, vol.38
, Issue.3
, pp. 543-551
-
-
Kelly, D.L.1
Raley, H.G.2
Lo, S.3
Wright, K.4
Liu, F.5
McMahon, R.P.6
Moolchan, E.T.7
Feldman, S.8
Richardson, C.M.9
Wehring, H.J.10
Heishman, S.J.11
-
152
-
-
73949157937
-
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
-
Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB. The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009. Schizophrenia Bulletin 2010;36(1):94-103.
-
(2010)
Schizophrenia Bulletin
, vol.36
, Issue.1
, pp. 94-103
-
-
Kreyenbuhl, J.1
Buchanan, R.W.2
Dickerson, F.B.3
Dixon, L.B.4
-
153
-
-
0036019541
-
Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: A critical evaluation of current evidence and directions for future research
-
Kumari V, Sharma T. Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: A critical evaluation of current evidence and directions for future research. Psychopharmacology 2002;162(2):97-101.
-
(2002)
Psychopharmacology
, vol.162
, Issue.2
, pp. 97-101
-
-
Kumari, V.1
Sharma, T.2
-
155
-
-
21844469006
-
Individual behavioural counselling for smoking cessation
-
Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD001292.pub2]
-
(2005)
Cochrane Database of Systematic Reviews
, Issue.2
-
-
Lancaster, T.1
Stead, L.F.2
-
157
-
-
33644874561
-
Smoking bans in psychiatric inpatient settings? A review of the research
-
Lawn S, Pols R. Smoking bans in psychiatric inpatient settings? A review of the research. The Australian & New Zealand Journal of Psychiatry 2005;39(10):866-85.
-
(2005)
The Australian & New Zealand Journal of Psychiatry
, vol.39
, Issue.10
, pp. 866-885
-
-
Lawn, S.1
Pols, R.2
-
158
-
-
0035018964
-
Incidence of cancer among persons with schizophrenia and their relatives
-
Lichtermann D, Ekelund J, Pukkala E, Tanskanen A, Lonnqvist J. Incidence of cancer among persons with schizophrenia and their relatives. Archives of General Psychiatry 2001;58(6):573-8.
-
(2001)
Archives of General Psychiatry
, vol.58
, Issue.6
, pp. 573-578
-
-
Lichtermann, D.1
Ekelund, J.2
Pukkala, E.3
Tanskanen, A.4
Lonnqvist, J.5
-
159
-
-
70350441886
-
Varenicline-induced mixed mood and psychotic episode in a patient with Schizoaffective Disorder
-
Liu ME, Tsai SJ, Yang ST. Varenicline-induced mixed mood and psychotic episode in a patient with Schizoaffective Disorder. CNS Spectrum 2009;14:346.
-
(2009)
CNS Spectrum
, vol.14
, pp. 346
-
-
Liu, M.E.1
Tsai, S.J.2
Yang, S.T.3
-
160
-
-
0029009101
-
Haloperidol increases smoking inpatients with schizophrenia
-
McEvoy JP, Freudenreich O, Levin ED, Rose JE. Haloperidol increases smoking inpatients with schizophrenia. Psychopharmacology 1995;119(1):124-126.
-
(1995)
Psychopharmacology
, vol.119
, Issue.1
, pp. 124-126
-
-
McEvoy, J.P.1
Freudenreich, O.2
Levin, E.D.3
Rose, J.E.4
-
161
-
-
80355136469
-
Suicidal behaviour and depression in smoking cessation treatments
-
Moore TJ, Furberg CD, Glenmullen J, Maltsberger JT, Singh S. Suicidal behaviour and depression in smoking cessation treatments. PLoS ONE 2011;6(11):e27016.
-
(2011)
PLoS ONE
, vol.6
, Issue.11
-
-
Moore, T.J.1
Furberg, C.D.2
Glenmullen, J.3
Maltsberger, J.T.4
Singh, S.5
-
162
-
-
67651091553
-
Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia
-
Moss TG, Sacco KA, Allen TM, Weinberger AH, Vessicchio JC, George TP. Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia. Drug and Alcohol Dependence 2009;104(1-2):94-9.
-
(2009)
Drug and Alcohol Dependence
, vol.104
, Issue.1-2
, pp. 94-99
-
-
Moss, T.G.1
Sacco, K.A.2
Allen, T.M.3
Weinberger, A.H.4
Vessicchio, J.C.5
George, T.P.6
-
163
-
-
0030845507
-
Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers
-
Olincy A, Young DA, Freedman R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biological Psychiatry 1997;42(1):1-5.
-
(1997)
Biological Psychiatry
, vol.42
, Issue.1
, pp. 1-5
-
-
Olincy, A.1
Young, D.A.2
Freedman, R.3
-
164
-
-
10844237451
-
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
-
Sacco KA, Bannon KL, George TP. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. Journal of Psychopharmacology 2004;18(4):457-74.
-
(2004)
Journal of Psychopharmacology
, vol.18
, Issue.4
, pp. 457-474
-
-
Sacco, K.A.1
Bannon, K.L.2
George, T.P.3
-
165
-
-
0034072939
-
Current models of nicotine dependence: What is known and what is needed to advance understanding of tobacco etiology among youth
-
Shadel WG, Shiffman S, Niaura R, Nichter M, Abrams DB. Current models of nicotine dependence: What is known and what is needed to advance understanding of tobacco etiology among youth. Drug and Alcohol Dependence 2000;59 Suppl 1:S9-22.
-
(2000)
Drug and Alcohol Dependence
, vol.59
, pp. S9-22
-
-
Shadel, W.G.1
Shiffman, S.2
Niaura, R.3
Nichter, M.4
Abrams, D.B.5
-
166
-
-
47149090424
-
Changes in psychiatric patients' thoughts about quitting smoking during a smoke-free hospitalization
-
Shmueli D, Fletcher L, Hall SE, Hall SM, Prochaska JJ. Changes in psychiatric patients' thoughts about quitting smoking during a smoke-free hospitalization. Nicotine & Tobacco Research 2008;10(5):875-81.
-
(2008)
Nicotine & Tobacco Research
, vol.10
, Issue.5
, pp. 875-881
-
-
Shmueli, D.1
Fletcher, L.2
Hall, S.E.3
Hall, S.M.4
Prochaska, J.J.5
-
167
-
-
18344399696
-
Group behaviour therapy programmes for smoking cessation
-
Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD001007.pub2]
-
(2005)
Cochrane Database of Systematic Reviews
, Issue.2
-
-
Stead, L.F.1
Lancaster, T.2
-
170
-
-
84870417682
-
Combined pharmacotherapy and behavioural interventions for smoking cessation
-
Stead LF, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD008286.pub2]
-
(2012)
Cochrane Database of Systematic Reviews
, Issue.10
-
-
Stead, L.F.1
Lancaster, T.2
-
171
-
-
84872173821
-
Nicotine replacement therapy for smoking cessation
-
Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD000146.pub4]
-
(2012)
Cochrane Database of Systematic Reviews
, Issue.11
-
-
Stead, L.F.1
Perera, R.2
Bullen, C.3
Mant, D.4
Hartmann-Boyce, J.5
Cahill, K.6
Lancaster, T.7
-
172
-
-
19644364115
-
Financial implications of cigarette smoking among individuals with schizophrenia
-
Steinberg ML, Williams JM, Ziedonis DM. Financial implications of cigarette smoking among individuals with schizophrenia. Tobacco Control 2004;13(2):206.
-
(2004)
Tobacco Control
, vol.13
, Issue.2
, pp. 206
-
-
Steinberg, M.L.1
Williams, J.M.2
Ziedonis, D.M.3
-
173
-
-
68949104832
-
Smoking Reduction and Cessation for People with Schizophrenia: Guidelines for General Practitioners
-
SANE Australia & Department of Psychiatry, University of Melbourne
-
Strasser K. Smoking Reduction and Cessation for People with Schizophrenia: Guidelines for General Practitioners. Smoking Reduction and Cessation for People with Schizophrenia:Guidelines for General Practitioners. SANE Australia & Department of Psychiatry, University of Melbourne, 2001.
-
(2001)
Smoking Reduction and Cessation for People with Schizophrenia:Guidelines for General Practitioners
-
-
Strasser, K.1
-
174
-
-
0141684982
-
Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy
-
Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. Journal of American Medical Association 2003;290(12):1624-32.
-
(2003)
Journal of American Medical Association
, vol.290
, Issue.12
, pp. 1624-1632
-
-
Tunis, S.R.1
Stryer, D.B.2
Clancy, C.M.3
-
176
-
-
14944375305
-
Outcome criteria in smoking cessation trials: proposal for a common standard
-
West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100(3):299-303.
-
(2005)
Addiction
, vol.100
, Issue.3
, pp. 299-303
-
-
West, R.1
Hajek, P.2
Stead, L.3
Stapleton, J.4
-
177
-
-
26844517607
-
Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect
-
Williams JM, Ziedonis DM, Abanyie F, Steinberg ML, Foulds J, Benowitz NL. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophrenia Research 2005;79(2-3):323-35.
-
(2005)
Schizophrenia Research
, vol.79
, Issue.2-3
, pp. 323-335
-
-
Williams, J.M.1
Ziedonis, D.M.2
Abanyie, F.3
Steinberg, M.L.4
Foulds, J.5
Benowitz, N.L.6
-
178
-
-
33744969290
-
Snuffing out tobacco dependence. Ten reasons behavioral health providers need to be involved
-
Williams JM, Ziedonis DM. Snuffing out tobacco dependence. Ten reasons behavioral health providers need to be involved. Behavioral Healthcare 2006;26(5):27-31.
-
(2006)
Behavioral Healthcare
, vol.26
, Issue.5
, pp. 27-31
-
-
Williams, J.M.1
Ziedonis, D.M.2
-
179
-
-
33845963166
-
-
2nd Edition. American Psychiatric Association
-
Workgroup on Substance Use Disorders, American Psychiatric Association Steering Committee on Practice Guidelines. Practice Guideline for the Treatment of Patients With Substance Use Disorders. 2nd Edition. American Psychiatric Association, 2006.
-
(2006)
Practice Guideline for the Treatment of Patients With Substance Use Disorders
-
-
-
181
-
-
58149483940
-
Smoking restrictions and treatment for smoking: policies and procedures in psychiatric inpatient units in Australia
-
Wye PM, Bowman JA, Wiggers JH, Baker A, Knight J, Carr VJ, et al. Smoking restrictions and treatment for smoking: policies and procedures in psychiatric inpatient units in Australia. Psychiatric Service 2009;60(1):100-7.
-
(2009)
Psychiatric Service
, vol.60
, Issue.1
, pp. 100-107
-
-
Wye, P.M.1
Bowman, J.A.2
Wiggers, J.H.3
Baker, A.4
Knight, J.5
Carr, V.J.6
-
182
-
-
0028222166
-
Nicotine dependence and schizophrenia
-
Ziedonis D, Kosten TR, Glazer WM, Frances RJ. Nicotine dependence and schizophrenia. Hospital and Community Psychiatry 1994;45(3):204-6.
-
(1994)
Hospital and Community Psychiatry
, vol.45
, Issue.3
, pp. 204-206
-
-
Ziedonis, D.1
Kosten, T.R.2
Glazer, W.M.3
Frances, R.J.4
-
183
-
-
36448964521
-
Program and System Level Interventions to Address Tobacco Amongst Individuals with Schizophrenia
-
Ziedonis D, Parks J, Zimmermann MH, McCabe P. Program and System Level Interventions to Address Tobacco Amongst Individuals with Schizophrenia. Journal of Dual Diagnosis 2007;3(3/4):151-175.
-
(2007)
Journal of Dual Diagnosis
, vol.3
, Issue.3-4
, pp. 151-175
-
-
Ziedonis, D.1
Parks, J.2
Zimmermann, M.H.3
McCabe, P.4
-
184
-
-
51349129883
-
-
Royal Australian College of General Practitioners
-
Zwar N, Richmond R, Borland R, Peters M, Stilman S, Litt J, et al. Smoking cessation pharmacotherapy: an update for health professionals. Royal Australian College of General Practitioners, 2007.
-
(2007)
Smoking cessation pharmacotherapy: an update for health professionals
-
-
Zwar, N.1
Richmond, R.2
Borland, R.3
Peters, M.4
Stilman, S.5
Litt, J.6
-
185
-
-
77951734628
-
Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis
-
Tsoi DT, Porwal M, Webster AC. Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis. British Journal of Psychiatry 2010;196:346-353.
-
(2010)
British Journal of Psychiatry
, vol.196
, pp. 346-353
-
-
Tsoi, D.T.1
Porwal, M.2
Webster, A.C.3
|